Precigen PGEN
$4.21 +$0.05 (+1.20%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $4.24 +0.61%
Open$4.16
Prev close$4.16
Day range$4.07 – $4.36
Volume6.07M
Market cap$1.51B
P/E (TTM)38.3
Dividend yield–
Earnings
Average move on report day±11.9%last 16 reports
Closed higher11 of 1669% of the time
Best reaction+25.6%
Worst reaction-16.5%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 4 Nov 2026 | After Market | ±18.8% | -16.52% | Within range |
| 2026/Q2 | 4 Aug 2026 | After Market | ±19.9% | +5.51% | Within range |
| 2026/Q1 | 13 May 2026 | After Market | ±13.9% | +10.84% | Within range |
| 2025/Q4 | 25 Mar 2026 | After Market | ±21.0% | +25.48% | Bigger than priced |
| 2025/Q3 | 13 Nov 2025 | After Market | ±10.9% | +25.65% | Bigger than priced |
| 2024/Q4 | 19 Mar 2025 | After Market | ±27.7% | +0.56% | Within range |
| 2024/Q2 | 14 Aug 2024 | After Market | ±92.9% | -4.46% | Within range |
| 2024/Q1 | 14 May 2024 | After Market | ±18.5% | +5.11% | Within range |
| 2023/Q4 | 19 Mar 2024 | After Market | ±34.8% | +0.00% | Within range |
| 2023/Q2 | 9 Aug 2023 | After Market | ±121.0% | +22.58% | Within range |
| 2023/Q1 | 10 May 2023 | After Market | ±111.6% | -5.79% | Within range |
| 2022/Q4 | 6 Mar 2023 | After Market | ±119.1% | +17.39% | Within range |
| 2022/Q3 | 9 Nov 2022 | After Market | ±74.8% | +21.09% | Within range |
| 2022/Q2 | 8 Aug 2022 | After Market | ±41.5% | +12.68% | Within range |
| 2022/Q1 | 9 May 2022 | After Market | ±117.4% | +12.17% | Within range |
| 2021/Q4 | 1 Mar 2022 | Pre Market | ±26.7% | -4.00% | Within range |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2026/Q3
By business line
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$74.15M+2,437.6% YoY
Operating profit$38.65M+212.1% YoY
Net profit$35.77M+124.4% YoY
Diluted EPS$0.08+107.5% YoY
Free cash flow$11.45M+138.9% YoY
Operating cash flow$11.88M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin91.4%
Operating margin21.4%
Net margin15.6%
Return on equity38.8%
Return on assets12.7%
Return on invested capital20.9%
Current ratio5.58
Liabilities / assets60.5%
Cash & investments$46.07M
Total debt$97.47M
Net cash (debt)-$51.40M
No comments yet — be the first to weigh in on PGEN.
Sign in to join the discussion.